Evaluating the Diagnostic Utility of High-Frame-Rate Contrast-Enhanced Ultrasound and a Nomogram for Lymphoma Assessment

• by Yu Song, Yahan Zhang, Linlin Zhang, Ying Che, Manxi Li

• November 19, 2025

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• by

• December 17, 2025

• 4 min

Prognostic Implications of Widespread FDG Uptake in Spleen and/or Bone Marrow Linked to Reticuloendothelial System Activation in Patients with Lymphoma

• by Yuru Song, Jiaqi Sun, Jing Jiang, Ningjun Xu, Qian Zhao

• January 17, 2026

Mechanisms of first-line treatment resistance in diffuse large B-cell lymphoma

• by Zhumei Zhan, Peipei Li, Yanlu Liu, Changqing Zhen, Ying Zhang, Ou Bai

• May 8, 2026